Clinical trial explores new ways to help chronic pain sufferers

December 18, 2015 by Emma Rayner
Clinical trial explores new ways to help chronic pain sufferers

Medication normally used to treat depression and anxiety could give new hope to chronic pain suffers.

Researchers at the Arthritis Research UK Pain Centre, based at The University of Nottingham and Nottingham City Hospital, are inviting people to take part in a clinical trial to determine whether a drug called Duloxetine can be used to treat chronic knee pain, known as .

Patients who participate in the study are put into one of two groups. One group is given Duloxetine, while the other group receives a dummy treatment, known as a placebo.

Diane Reckziegel from The University of Nottingham and Chief Investigator for the study, said: "As we get older or sustain injuries our joints, especially the knees, begin to show signs of deterioration. This causes pain that may become chronic over time.

"The most effective treatments for knee osteoarthritis are typically quite invasive, involving steroid injections into the joint or surgery to remove the diseased joint, which is then replaced with an artificial joint."

Before taking the medication patients undergo MRI scans of their brain. After the six week course of medication they then return for an MRI scan where the effects of the medication will be assessed through questionnaires, imaging and sensory tests.

Diane added: "Duloxetine has already been shown to be effective in relieving different types of chronic pain, however what we don't know is how this drug works to reduce pain, and to whom it may be more useful.

"By comparing the brains of patients with osteoarthritis before and after the treatment we hope to achieve a better understanding of the mechanisms of . This will help us select patients who might benefit more from Duloxetine treatment, hopefully avoiding the need for invasive procedures."

The trial, which began at the start of the year, is aiming to recruit 81 patients before May 2016. So far 44 patients have been recruited.

One patient who is taking part in the trial is 64-year-old Catherine Parnaby from Keyworth. The retired school supervisor was diagnosed with osteoarthritis eight years ago. She said: "My knees get very painful, even painkillers don't work at times. I joined the trial after receiving a letter from my GP and wanted to see if a different approach would help my pain."

During the trial Catherine was unaware whether she was taking Duloxetine or the placebo, however after the trial she was told that she was on the Duloxetine drug. Catherine said: "During the trial my pain went away. I was able to swim further and walk quicker and the tablets I took were much better than the painkillers I had been taking. I really hope this trial makes a difference and Duloxetine becomes a recognized treatment for osteoarthritis because it helped me.

"If anyone else gets the chance to get involved in this trial then I would tell them to go ahead and try it. It was great for me."

The Arthritis Research UK Pain Centre is a partnership between NUH, The University of Nottingham and Arthritis Research UK. It is hosted at Nottingham City Hospital and was established over five years ago to investigate the mechanisms that lead to the experienced by sufferers of arthritis and improve the treatment of .

Explore further: Women with knee osteoarthritis experience greater pain sensitivity than men

Related Stories

Women with knee osteoarthritis experience greater pain sensitivity than men

October 5, 2015
Among patients with osteoarthritis of the knee, women experienced greater sensitivity to various pain modalities—such as lower tolerance to heat, cold, and pressure—and greater widespread pain than men.

How effective is total knee replacement in patients with rheumatoid arthritis?

July 20, 2015
Studies that have assessed the effects of total knee replacement on quality of life are scarce and have been almost exclusively limited to patients with osteoarthritis, even though rheumatoid arthritis is the most common ...

Medication duloxetine helps reduce pain from chemotherapy

April 2, 2013
Among patients with painful chemotherapy-induced peripheral neuropathy, use of the anti-depressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a study in the April ...

Pain relief, function up post knee replacement in arthritis

October 22, 2015
(HealthDay)—Total knee replacement usually results in greater pain relief and better joint function after a year than nonsurgical osteoarthritis treatment, researchers report in the Oct. 22 issue of the New England Journal ...

Knee arthritis: Steroid shots may not help long-term, ozone injections promising

November 10, 2015
(HealthDay)—Millions of aging Americans are plagued by arthritic knees, and two new studies offer insight into what might—or might not—help curb the condition.

Reducing pain in patients with osteoarthritis of the big toe

December 7, 2015
Prefabricated foot orthoses and rocker-sole footwear (in which the sole of the shoe is curved) are effective at reducing peak pressure under the big toe in people with a condition called first metatarsophalangeal joint osteoarthritis, ...

Recommended for you

Study shows prevalence of knee osteoarthritis has doubled since World War II

August 14, 2017
The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons most might think.

Researchers find arthritis drug could treat blood cancer patients

August 3, 2017
Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.